Status:
UNKNOWN
Preoperative Concurrent Chemoradiotherapy for Locally Advanced Gastroesophageal Junction or Upper Gastric Adenocarcinoma
Lead Sponsor:
Peking University
Collaborating Sponsors:
Chinese PLA General Hospital
Peking University People's Hospital
Conditions:
Gastroesophageal Junction Adenocarcinoma
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
PHASE3
Brief Summary
Preoperative chemoradiotherapy(CRT) had been introduced in the comprehensive treatment of gastroesophageal junction and upper gastric cancers in the decade.According to some researches,CRT had shown i...
Eligibility Criteria
Inclusion
- Histologically proven adenocarcinoma of the gastroesophageal junction.
- Clinical stage diagnosed by endoscopic ultrasound(EUS) or computed tomography(CT) as T3-4NxM0 tumors,according to American Joint Committee on Cancer (AJCC) 7th edition.
- Eastern Cooperative Oncology Group (ECOG) performance status≤2.
- Informed consent obtained.
Exclusion
- Combined with other malignant tumors.
- Eastern Cooperative Oncology Group (ECOG) performance status\>2.
- Combined with severe organ dysfunction.
- Pregnancy
Key Trial Info
Start Date :
January 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2020
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT02193594
Start Date
January 1 2014
End Date
May 1 2020
Last Update
June 8 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Haidian District, Beijing Municipality, China, 100142